Sign In
Buy ATNX
$0.203
+0 (+0%)
At Close: Aug 23, 2023
Athenex Exits 503B Sterile Compounding Business
08:00am, Friday, 16'th Dec 2022
Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year
Athenex Announces Positive Results of Special Stockholder Meeting
10:30am, Tuesday, 22'nd Nov 2022
BUFFALO, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for
Athenex Announces Closing of the Sale of its China API Business
08:00am, Monday, 21'st Nov 2022
BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for
Athenex, Inc. (ATNX) CEO Johnson Lau on Q3 2022 Results - Earnings Call Transcript
01:43am, Sunday, 06'th Nov 2022
Athenex, Inc. (NASDAQ:ATNX ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Tim McCarthy - MD, Investor Relations Johnson Lau - Chief Executive Officer Dan Lang - Pr
Athenex (ATNX) Reports Q3 Loss, Tops Revenue Estimates
09:48am, Thursday, 03'rd Nov 2022
Athenex (ATNX) delivered earnings and revenue surprises of 12.50% and 16.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Athenex to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
11:00am, Tuesday, 06'th Sep 2022
BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the
Penny Stocks to Buy Premarket on August 5th? 3 to Watch
06:00am, Friday, 05'th Aug 2022
Here's what you need to know about buying penny stocks on August 5th? The post Penny Stocks to Buy Premarket on August 5th?
Athenex, Inc. (ATNX) CEO Johnson Lau on Q2 2022 Results - Earnings Call Transcript
08:06pm, Thursday, 28'th Jul 2022
Athenex, Inc. (NASDAQ:ATNX ) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Caileigh Dougherty - Director, Investor Relations Johnson Lau - Chief Executive Officer Dan
Athenex, Inc.'s (ATNX) CEO Johnson Lau on Q1 2022 Results - Earnings Call Transcript
01:19pm, Tuesday, 10'th May 2022
Athenex, Inc. (NASDAQ:ATNX ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Caileigh Dougherty - Investor Relations Johnson Lau - Chief Executive Officer Daniel Lang - P
Athenex, Texas Children's Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine to Present Phase 1 Clinical Data for KUR-501, an autologous GD2 CAR-NKT Cell Therapy for Relapsed/Refractory High Risk Neuroblastoma at the ASGCT 25th Annual Meeting
05:27pm, Monday, 02'nd May 2022
BUFFALO, N.Y., May 02, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the tre
Athenex 提供 2021 年第四季度及該年全年度財務業績並提供業務更新
11:44am, Thursday, 17'th Mar 2022 GlobeNewswire Inc.
宣佈以細胞療法計劃為焦點的策略重心
Athenex GAAP EPS of -$0.95 misses by $0.62, revenue of $24.94M misses by $5.88M
09:07pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Athenex press release (NASDAQ:ATNX): Q4 GAAP EPS of -$0.95 misses by $0.62.Revenue of $24.94M (+14.4% Y/Y) misses by $5.88M.
Athenex implements cost saving measures as liquidity dries up
08:51pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Buffalo, New York-based biotech Athenex (ATNX) said on Wednesday that the company is implementing cost-cutting measures and monetization of non-core assets to extend the cash runway…
Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2021 Results - Earnings Call Transcript
08:50pm, Wednesday, 16'th Mar 2022
Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2021 Results - Earnings Call Transcript
Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
08:10pm, Wednesday, 16'th Mar 2022 GlobeNewswire Inc.
Announces Strategic Pivot to Focus on Cell Therapy Programs
